Skip to content

Weaning Form Mechanical Ventilation Using Extracorporeal CO2 Removal

A Pilot Study on the Use of Extracorporeal CO2 Removal During the Weaning Process From Mechanical Ventilation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02259335
Acronym
WeanPRO
Enrollment
15
Registered
2014-10-08
Start date
2014-10-31
Completion date
2017-10-31
Last updated
2016-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Acute Hypercapnic Respiratory Failure

Keywords

weaning from mechanical ventilation, extracorporeal CO2 removal, post-extubation failure

Brief summary

Weaning from invasive mechanical ventilation is one of the major clinical problem especially ion those patients with a pre-existing chronic respiratory disease and chronic hypercpania. The aim of this pilot feasibility and safety trial is to assess the possibility of shorten the duration of mechanical ventilation using a device able to remove CO2 and theoretically able to allow therefore the praecox extubation

Detailed description

Weaning from invasive mechanical ventilation is one of the major clinical problem especially ion those patients with a pre-existing chronic respiratory disease and chronic hypercpania. Up to 60% of the ventilatory time is devoted in these patients to the process of weaning. These patients very often fail several weaning attempt, when a T-piece trial method is used. In this case they are also very likely to require tracheotomy. In this study we will enroll those still hypercapnic patients fitting the criteria of readiness to be wean (i.e. clinical stability, normal sensorium and good cough reflex) and failing a T-piece trail because of a rise in PaCO2 (\>20% from baseline) and/or a rapid shallow breathing index (f/VT)\> 100. After the unsuccessful trial they will be reconnected to the ventilator and they will repeat hours later the same T-piece trial once the extracorporeal CO2 removal device (DeCap) will be connected via a double lumen catheter in the femoral vein. The investigators aim to verify whether using the DeCap) the investigators will be able to avoid at the end of the T-piece trial the criteria of failure. If so, the patient will be extubated and DeCap will be continued when all of the following were achieved for at least 12 hours: respiratory rate less than 25 breaths/min; pH greater than 7.35; Paco2 less than 20% of the baseline value; and absence of use of the accessory muscles or paradoxical abdominal movements.

Interventions

A device able to remove CO2 using a dedicated device connected to the patient via a double lumen catheter inserted in the femoral vein

Sponsors

University of Turin, Italy
CollaboratorOTHER
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients meeting the criteria for readiness to be weaned (i.e. clinical stability, FiO2\<50%, normal sensorium, body temperature \< 38 and satisfactory cough reflex) * Failing a T-piece trial after 1 hour or before for a rise in PaCO2\>20% from baseline and with f/VT ratio \>100

Exclusion criteria

* Patients NOT meeting the criteria for readiness to be weaned * Patients succeeding a T-piece trial

Design outcomes

Primary

MeasureTime frameDescription
passing a weaning trial using a T-piece method1 houravoiding to reach the criteria of weaning failure
weaning success48 hoursavoiding reintubation after removal of DeCap

Secondary

MeasureTime frame
Physiological variables (i.e. Arterial Blood Gases, vitals and dyspnea)48 hours

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026